Phase I Clinical Trial of the 131I-Labeled Anticarcinoembryonic Antigen CIGB-M3 Multivalent Antibody Fragment-Reference-Cited by-同舟云学术

Phase I Clinical Trial of the 131I-Labeled Anticarcinoembryonic Antigen CIGB-M3 Multivalent Antibody Fragment

Published:2011-06 Issue:3 Volume:26 Page:353-363
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

González Gilmara Pimentel¹,García Idrian García²,González Joaquín González¹,Sánchez Lincidio Pérez³,Mirabal Milagros Velasco¹,Marín Carlos Calderón¹,Ruiz Fausto L. García¹,Iglesias Elizeth Garcia²,de Queralta Rosalina López⁴,Toirac Ramón Ropero¹,Ávila Marta Ayala³,Díaz Adlín López⁴,Saura Pedro A. López²,Gavilondo Jorge V.³,González Juan P. Oliva¹

Affiliation:

1. Nuclear Medicine Department, National Institute of Oncology and Radiobiology, La Habana, Cuba.

2. Clinical Trials Division, Cancer Research Department, Center for Genetic Engineering and Biotechnology (CIGB), La Habana, Cuba.

3. Recombinant Antibody Group Laboratory, Pharmaceuticals Division, Cancer Research Department, Center for Genetic Engineering and Biotechnology (CIGB), La Habana, Cuba.

4. Nuclear Medicine Department, “Hermanos Ameijeiras” Hospital, La Habana, Cuba.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2010.0899

Reference34 articles.

1. Current status of cancer therapy with radiolabeled monoclonal antibody

2. Targeted therapy in nuclear medicine—current status and future prospects

3. Antibody-guided radiation therapy of cancer

4. Cure of incurable lymphoma

5. Iodine-131 tositumomab (Bexxar) in a radiation oncology environment

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carrier systems of radiopharmaceuticals and the application in cancer therapy;Cell Death Discovery;2024-01-09

2. Delivery of radioimmunotherapy for solid tumors;Systemic Drug Delivery Strategies;2022

3. Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials;Cancers;2021-11-07

4. Antibody fragment and targeted colorectal cancer therapy: A global systematic review;Current Pharmaceutical Biotechnology;2021-08-10

5. General overview of radioimmunotherapy of solid tumors;Immunotherapy;2013-05